Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group
- PMID: 40736768
- PMCID: PMC12326964
- DOI: 10.1530/ETJ-25-0035
Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group
Abstract
Background: Pediatric differentiated thyroid carcinoma (pedDTC) is rare but increasingly prevalent, requiring multidisciplinary care to ensure optimal outcomes. In 2021, the pediatric national reference program of the German Malignant Endocrine Tumor (MET) registry was established to standardize the management of pedDTC, with a particular focus on radioactive iodine (RAI) use and minimizing treatment variability.
Methods: This study evaluated the program's first 3.5 years, including 43 inquiries concerning 39 patients with confirmed or suspected pedDTC. A weekly national expert tumor board provided individualized recommendations based on multidisciplinary input and risk stratification. Data were analyzed for demographic trends, therapeutic decisions, and short-term outcomes.
Results: Among 34 patients with confirmed pedDTC, RAI use was reduced or omitted in 70.6% of cases, particularly among low-risk patients, in alignment with the American Thyroid Association 2015 guidelines. Surgical strategies were modified in 61.5% of cases to balance disease control with treatment-related morbidity. No systemic medical therapy was recommended during initial management. At a mean follow-up of 0.7 years, all patients were alive; persistent disease was observed in 15.4%.
Conclusions: The national reference program has successfully introduced a structured, individualized approach to the management of pedDTC in Germany. Ongoing data collection and longer follow-up will be essential to assess the long-term impact of this centralized, risk-adapted model.
Keywords: children and adolescents; differentiated thyroid carcinoma; radioactive iodine therapy; reference program.
Conflict of interest statement
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work reported.
Figures
Similar articles
-
The Definition of Recurrence of Differentiated Thyroid Cancer: A Systematic Review of the Literature.Thyroid. 2024 Nov;34(11):1324-1334. doi: 10.1089/thy.2024.0271. Epub 2024 Oct 2. Thyroid. 2024. PMID: 39283824
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.Lancet. 2025 Jul 5;406(10498):52-62. doi: 10.1016/S0140-6736(25)00629-4. Epub 2025 Jun 18. Lancet. 2025. PMID: 40543520 Clinical Trial.
-
Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer.Future Oncol. 2024 Dec;20(40):3463-3470. doi: 10.1080/14796694.2024.2433407. Epub 2024 Dec 13. Future Oncol. 2024. PMID: 39670327
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
References
-
- Erdmann F, Kaatsch P, Grabow D, et al. German Childhood Cancer Registry – Annual Report 2019 (1980–2018). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at The University Medical Center of The Johannes Gutenberg University Mainz, 2020.
-
- Kuhlen M, Wellbrock M, Kunstreich M, et al. Incidence and temporal patterns of differentiated thyroid carcinoma in children and adolescents in Germany: a pooled analysis based on data from the German malignant endocrine tumor registry and the German childhood cancer registry. Thyroid 2024. 34 1540–1550. ( 10.1089/thy.2024.0534) - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous